Now Bingo, you basically just said nothing. You really write a lot but miss the point.
Recurring revenue is the key, a business that has to rely on continually selling units ie finding new buyers will always trade at a discount. To say it would be nice, is missing the point, its essential.
All the science has led no where, that is the point. At what point do you actually have to deliver? At what point does the market switch off? Look at the liquidity in the stock, its not good. Anyone wanting out has to wait, so as soon as any good news arrives massive selling into the spike it triggered which is exactly what happened last week re Ventitest. That is how the market operates. It can work in your favor if you can punch through the selling pressure but with no broker support it is very hard to do. No broker researches the company. There is little interest in the stock, despite this so called 'science'.
And if you knew anything about markets and how they trade you would know that often you get moves on the open and close because you can sell volume into the match. And in the close you will often see a leg down or up in any stock because orders are being closed out. In case you missed it we have seen regular +/- half a percent moves or more in the close.
Maybe you should try managed funds because you clearly are not really suited to direct equities. Or maybe go through a broker who can educate you.
UCM Price at posting:
20.0¢ Sentiment: None Disclosure: Held
